Moderate physical activity is critical for reducing the risk of chronic disease in older women

January 14, 2003

Getting regular, moderate-intensity exercise may be critically important for postmenopausal women who want to reduce their risk of cancer, heart disease and other chronic diseases, according to a study led by researchers at Fred Hutchinson Cancer Research Center in Seattle. The reason: exercise effectively reduces intra-abdominal fat, a hidden risk factor for many chronic illnesses.

Lead investigator Anne McTiernan, M.D., Ph.D., a member of Fred Hutchinson's Public Health Sciences Division, and colleagues report the results of the largest randomized clinical trial to assess the effect of exercise on overall and intra-abdominal obesity in postmenopausal women in the Jan. 15 issue of the Journal of the American Medical Association. Researchers from Fred Hutchinson, the University of Washington, Yale University and the University of Colorado collaborated on the study.

"Even if a woman who exercises regularly doesn't see the benefits of dramatic weight loss on her scale, our results indicate that she can feel confident that she is improving her health, because regardless of the amount of weight lost, we now know that exercise reduces hidden intra-abdominal fat, the most dangerous type of fat," said McTiernan, director of Fred Hutchinson's Prevention Center and an international expert on the impact of physical activity on cancer prevention. "This study gives us direct evidence that exercise can affect biology related to cancer and other chronic diseases in older women."

Reducing intra-abdominal, or visceral, fat is important because in addition to increasing the risk of cardiovascular disease and diabetes, among other conditions, such fat can raise insulin levels, which promotes the growth of cancer cells.

People with high levels of intra-abdominal fat may not even know it, McTiernan said, because it is hidden, deposited around the internal organs within the abdomen. "Most women don't know about intra-abdominal fat, but they should, since it is the most clinically significant type of fat and it's where women tend to store fat after menopause."

Although it is known that so-called "apple-shaped" people who store their fat around the stomach are at higher risk for conditions such as diabetes, hypertension and stroke than "pear-shaped" people who store their fat in their buttocks and thighs, visceral obesity is not necessarily correlated with body shape, McTiernan said. The only accurate way to determine the presence and extent of intra-abdominal fat is with imaging procedures such as CT or MRI scans.

"Because it is so costly to measure intra-abdominal obesity, until now very little data has existed on the impact of exercise on this dangerous, hidden health risk," she said.

This yearlong study involved more than 170 previously sedentary, overweight, postmenopausal Seattle-area women. None took hormone-replacement therapy. Half were randomly assigned to a moderate-intensity, aerobic-exercise group and half, who served as a comparison group, attended a weekly hour-long stretching class.

The members of the exercise group, who worked out at home and at a gym for at least 45 minutes five days a week - an amount similar to current national recommendations - achieved significant reductions in weight, total body fat and intra-abdominal fat. After a year on the program, while the amount of body weight lost was modest yet statistically significant, the exercisers lost between 3.4 percent and 6.9 percent intra-abdominal fat while maintaining their calorie intake. Women who had the highest adherence to the program experienced the largest decreases in weight, total and intra-abdominal fat. The women in the stretching group, in contrast, experienced a slight gain in intra-abdominal fat.

"The beauty of exercise as a method to reduce total and intra-abdominal fat - and therefore chronic disease - is that it can be done by most women at low cost and with low risk of side effects. In addition, exercise has many other health benefits. The good news is that it is never too late to enjoy the health benefits of exercise," McTiernan said.

Strengths of this study, compared to two previous trials that looked at the impact of activity on intra-abdominal obesity, include its large sample size (173 versus fewer than 25 subjects), the length of the exercise intervention (one year compared to less than six months), and its high adherence rates (81 percent of the exercisers completed 80 percent or more of their prescribed 225 minutes per week of exercise).

Another strength of this study was its randomized, controlled, clinical-trial design, considered the gold standard of study designs in medicine. The participants met three times a week with an exercise physiologist at an exercise facility, where they performed treadmill walking and stationary biking. They also exercised two days a week at home, doing exercises of their own choosing, mostly walking.

"In this type of study, we can directly control for extraneous factors and we directly observe what the women are doing rather than just relying on what they report on questionnaires. Therefore, we have more confidence in the results," she said.

The results of the study, funded by the National Cancer Institute, are significant for older women who seek a natural way to reduce their risk of chronic disease, said McTiernan, who is also a research associate professor at the University of Washington School of Medicine and School of Public Health and Community Medicine.

"Most American women gain one to two pounds on average every year, and that adds up to dangerous levels over a lifetime. All women - especially those at risk for diabetes, cardiovascular disease, cancer or high cholesterol - need to stop gaining weight," she said. "Regular, moderate-intensity exercise can help keep the weight from creeping on, which can translate to improved health in the long run."
-end-
The Fred Hutchinson Cancer Research Center, home of two Nobel Prize laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and other potentially fatal diseases. Fred Hutchinson receives more funding from the National Institutes of Health than any other independent U.S. research center. Recognized internationally for its pioneering work in bone-marrow transplantation, the center's four scientific divisions collaborate to form a unique environment for conducting basic and applied science. Fred Hutchinson is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest and is one of 41 nationwide. For more information, visit the center's Web site at www.fhcrc.org.

Advancing Knowledge, Saving Lives

Fred Hutchinson Cancer Research Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.